Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ron Ziegler

This article was originally published in The Tan Sheet

Executive Summary

Former National Association of Chain Drug Stores CEO Ronald Ziegler died of a heart attack Feb. 10 at the age of 63. Ziegler served as head of NACDS from January 1988 until February 1999, when he left the association for health reasons (1"The Tan Sheet" Feb. 15, 1999, p. 24). Under his leadership, NACDS quadrupled in size from $7 mil. in revenues and 25 staffers to over $28 mil. in revenues and 95 employees by the end of his tenure. Ziegler, who was living in Coronado, Calif. at the time of his death, is survived by his wife Nancy, his mother and two daughters...

You may also be interested in...


Robert Hannan will serve as interim president and CEO following Ronald Ziegler's retirement Feb. 28. Hannan was president and CEO of Thrift Drug for 10 years until the chain was acquired by J.C. Penney and merged with Eckerd in 1997. After serving as Eckerd vice chairman during the transition, Hannan retired in 1998. He was NACDS chairman from 1993 to 1994. Ziegler will retire at the end of February "because of health reasons," NACDS announces Feb. 8. Ziegler previously said he would retire in December 2000 after a successor was named ("The Tan Sheet" Feb. 1, p. 27). However, in a series of meetings with the association board in Miami, "he concluded that it was in his best interest to initiate his retirement sooner than originally planned," NACDS says. The association emphasizes that "Ziegler and the entire board hold one another in the highest regard and in the highest terms of respect"

QUOTED. 25 January. 2021. Scott Whitaker.

US President Joe Biden has invoked the Defense Production Act to ramp up COVID-19 tests and personal protective equipment. See what AdvaMed’s CEO Scott Whitaker wrote in a letter to Biden where he asked that the device industry be included in the administration’s decision-making process.

Quick Listen: Scrip’s Five Must-Know Things

Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts